Lisata Therapeutics
LSTA
31 hedge funds and large institutions have $12M invested in Lisata Therapeutics in 2013 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 7 increasing their positions, 1 reducing their positions, and 7 closing their positions.
811% more call options, than puts
Call options by funds: $82K | Put options by funds: $9K
600% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 1
157% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 7
154% more capital invested
Capital invested by funds: $4.71M → $12M (+$7.27M)
55% more funds holding
Funds holding: 20 → 31 (+11)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$970K |
| 2 |
SC
Sophrosyne Capital
New York
|
+$526K |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$500K |
| 4 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$474K |
| 5 |
Bank of New York Mellon
New York
|
+$412K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LOM
Loeb Offshore Management
New York
|
-$83K |
| 2 |
FHC
First Heartland Consultants
Lake St. Louis,
Missouri
|
-$56K |
| 3 |
Neuberger Berman Group
New York
|
-$38K |
| 4 |
GC
Guggenheim Capital
Chicago,
Illinois
|
-$29K |
| 5 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
-$26K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
TRCT
26
Tower Research Capital (TRC)
New York
| $6K | +$4.44K | +4 | New |
|
27
Ameriprise
Minneapolis,
Minnesota
| $3K | – | – | – |
|
28
Wells Fargo
San Francisco,
California
| $1K | – | – | – |
|
29
AllianceBernstein
Nashville,
Tennessee
| $1K | +$1.11K | +1 | New |
|
30
Creative Planning
Overland Park,
Kansas
| $1K | +$1.11K | +1 | New |
|
31
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
| $2 | +$1.11K | +1 | New |
|
|
LOM
32
Loeb Offshore Management
New York
| – | -$83K | -100 | Closed |
|
|
FHC
33
First Heartland Consultants
Lake St. Louis,
Missouri
| – | -$56K | -67 | Closed |
|
|
34
Neuberger Berman Group
New York
| – | -$38K | -46 | Closed |
|
|
GC
35
Guggenheim Capital
Chicago,
Illinois
| – | -$29K | -34 | Closed |
|
|
36
Commonwealth Equity Services
Waltham,
Massachusetts
| – | -$26K | -31 | Closed |
|
|
TMC
37
Trellus Management Company
Delray Beach,
Florida
| – | -$11K | -13 | Closed |
|
|
DC
38
Davenport & Co
Richmond,
Virginia
| – | -$8.32K | -10 | Closed |
|
|
AIG
39
American International Group
New York
| – | -$1 | – | – |
|
LSTA Hedge Fund Activity: Q3 2013 in Review
31 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in Lisata Therapeutics (LSTA) for Q3 2013, worth a combined $12M — up 154% from $4.71M a quarter earlier.
Buyers outnumbered sellers: 18 funds opened new LSTA positions and 7 closed out — a net gain of 11 holders — while 7 added to existing stakes and 1 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $970K. The largest seller was Loeb Offshore Management, exiting entirely with an estimated $83K sold.
- 31 institutional investors held Lisata Therapeutics (LSTA) as of Q3 2013, up from 20 in Q2 2013.
- Funds reported $12M of Lisata Therapeutics stock for Q3 2013, up 154% quarter-over-quarter.
- 18 funds opened new Lisata Therapeutics positions in Q3 2013 and 7 closed out, a net change of +11 holders.
- The largest Lisata Therapeutics buyer in Q3 2013 was Morgan Stanley, an estimated $970K added.
- The largest Lisata Therapeutics seller in Q3 2013 was Loeb Offshore Management, an estimated $83K sold.
Based on aggregated 13F filings for Q3 2013.